TMVIX
Price
$26.13
Change
-$0.14 (-0.53%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

TMVIX vs VIMSX

Header iconTMVIX vs VIMSX Comparison
Open Charts TMVIX vs VIMSXBanner chart's image
Timothy Plan Large/Mid Cap Value I
Price$26.13
Change-$0.14 (-0.53%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TMVIX vs VIMSX Comparison Chart
Loading...
VS
TMVIX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMVIX is a StrongBuy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. TMVIX (354M). VIMSX pays higher dividends than TMVIX: VIMSX (1.38) vs TMVIX (0.62). TMVIX was incepted earlier than VIMSX: TMVIX (11 years) vs VIMSX (26 years). TMVIX is a more actively managed with annual turnover of: 17.00 vs. VIMSX (13.00). VIMSX has a lower initial minimum investment than TMVIX: VIMSX (3000) vs TMVIX (100000). TMVIX annual gain was more profitable for investors over the last year : 26.53 vs. VIMSX (25.11). VIMSX return over 5 years is better than : 56.75 vs. TMVIX (40.41).
TMVIXVIMSXTMVIX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years26 years-
Gain YTD16.28812.557130%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets354M172B0%
Annual Yield % from dividends0.621.3845%
Returns for 1 year26.5325.11106%
Returns for 3 years18.519.82189%
Returns for 5 years40.4156.7571%
Returns for 10 years35.93128.2128%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma